» Articles » PMID: 36052220

A Small Animal Model of Chronic Hepatitis E Infection Using Immunocompromised Rats

Abstract

Background & Aims: HEV variants such as swine genotypes within species (HEV-A) and rat HEV (; HEV-C1) cause chronic hepatitis E in immunocompromised individuals. There are few reliable and accessible small animal models that accurately reflect chronic HEV infection. We aimed to develop an immunocompromised rat model of chronic hepatitis E infection.

Methods: In this animal model infection study, rats were immunosuppressed with a drug combination (prednisolone, tacrolimus, and mycophenolate mofetil) commonly taken by transplant recipients. Rats were challenged with human- and rat-derived HEV-C1 strains or a human-derived HEV-A strain. Viral load, liver function, liver histology, humoural, and cellular immune responses were monitored.

Results: A high-dose (HD) immunosuppressive regimen consistently prolonged human- and rat-derived HEV-C1 infection in rats (up to 12 weeks post infection) compared with transient infections in low-dose (LD) immunosuppressant-treated and immunocompetent (IC) rats. Mean HEV-C1 viral loads in stool, serum, and liver tissue were higher in HD regimen-treated rats than in LD or IC rats ( <0.05). Alanine aminotransferase elevation was observed in chronically infected rats, which was consistent with histological hepatitis and HEV-C1 antigen expression in liver tissue. None (0/6) of the HD regimen-treated, 5/6 LD regimen-treated, and 6/6 IC rats developed antibodies to HEV-C1 in species-specific immunoblots. Reversal of immunosuppression was associated with clearance of viraemia and restoration of HEV-C1-specific humoural and cellular immune responses in HD regimen-treated rats, mimicking patterns in treated patients with chronic hepatitis E. Viral load suppression was observed with i.p. ribavirin treatment. HD regimen-treated rats remained unsusceptible to HEV-A infection.

Conclusions: We developed a scalable immunosuppressed rat model of chronic hepatitis E that closely mimics this infection phenotype in transplant recipients.

Lay Summary: Convenient small animal models are required for the study of chronic hepatitis E in humans. We developed an animal model of chronic hepatitis E by suppressing immune responses of rats with drugs commonly taken by humans as organ transplant rejection prophylaxis. This model closely mimicked features of chronic hepatitis E in humans.

Citing Articles

Cell binding tropism of rat hepatitis E virus is a pivotal determinant of its zoonotic transmission to humans.

Guo H, Xu J, Situ J, Li C, Wang X, Hou Y Proc Natl Acad Sci U S A. 2024; 121(45):e2416255121.

PMID: 39467126 PMC: 11551445. DOI: 10.1073/pnas.2416255121.


Hepatitis E virus immunosuppressed animal models.

Yadav K, Kenney S BMC Infect Dis. 2024; 24(1):965.

PMID: 39266958 PMC: 11395946. DOI: 10.1186/s12879-024-09870-4.


Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits.

He Q, Liu T, Yang X, Yuan D, Lu Q, Li Y J Virol. 2024; 98(7):e0084624.

PMID: 38899900 PMC: 11264948. DOI: 10.1128/jvi.00846-24.


Rat hepatitis E virus exposure in cats and dogs, Hong Kong.

Shun E, Situ J, Tsoi J, Wu S, Cai J, Lo K Emerg Microbes Infect. 2024; 13(1):2337671.

PMID: 38551320 PMC: 11018080. DOI: 10.1080/22221751.2024.2337671.


as an Emerging Cause of Acute Hepatitis Worldwide.

Benavent S, Carlos S, Reina G Microorganisms. 2023; 11(12).

PMID: 38138140 PMC: 10745784. DOI: 10.3390/microorganisms11122996.


References
1.
Wang Y, Zhou X, Debing Y, Chen K, van der Laan L, Neyts J . Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus. Gastroenterology. 2014; 146(7):1775-83. DOI: 10.1053/j.gastro.2014.02.036. View

2.
Kamar N, Garrouste C, Haagsma E, Garrigue V, Pischke S, Chauvet C . Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011; 140(5):1481-9. DOI: 10.1053/j.gastro.2011.02.050. View

3.
Sayed I, Foquet L, Verhoye L, Abravanel F, Farhoudi A, Leroux-Roels G . Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Res. 2017; 141:150-154. DOI: 10.1016/j.antiviral.2017.02.011. View

4.
Zhang W, Ami Y, Suzaki Y, Doan Y, Muramatsu M, Li T . Mongolia Gerbils Are Broadly Susceptible to Hepatitis E Virus. Viruses. 2022; 14(6). PMC: 9229706. DOI: 10.3390/v14061125. View

5.
Yang F, Li Y, Li Y, Jin W, Duan S, Xu H . Experimental Cross-Species Transmission of Rat Hepatitis E Virus to Rhesus and Cynomolgus Monkeys. Viruses. 2022; 14(2). PMC: 8880335. DOI: 10.3390/v14020293. View